SPOTLIGHT -
Dan Wetherill is a partner at Beghou Consulting.
To Reduce Commercial Risk for Orphan Drugs, Transform Forecasting
To successfully commercialize orphan drugs, companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities.
Data Analytics: Strength — and Solutions — in Numbers
Dan Wetherill offers three priorities for how pharma companies can better use data analytics to engage customers.